A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.

Clinical trial NCT02733068 · COMPLETED

Trial details

NCT number: NCT02733068
Sponsor: Shanghai Zerun Biotechnology Co.,Ltd
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Human Papilloma Virus Infection Type 16 Human Papilloma Virus Infection Type 18 Cervical Intraepithelial Neoplasia

Start date: 2014-11-02
Primary completion: 2019-07-30
Enrollment: 12000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.